Myriad Genetics
MYGN
#4986
Rank
โ‚ฌ1.32 B
Marketcap
14,50ย โ‚ฌ
Share price
-1.18%
Change (1 day)
-9.40%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ0.33 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are โ‚ฌ0.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.32 B12.66%
2022-12-31โ‚ฌ0.29 B-6.39%
2021-12-31โ‚ฌ0.31 B
2020-06-30โ‚ฌ0.43 B3.96%
2019-06-30โ‚ฌ0.41 B132.73%
2018-06-30โ‚ฌ0.17 B-53.61%
2017-06-30โ‚ฌ0.38 B223.88%
2016-06-30โ‚ฌ0.11 B28.27%
2015-06-30โ‚ฌ92.75 M20.76%
2014-06-30โ‚ฌ76.8 M32.83%
2013-06-30โ‚ฌ57.82 M33.14%
2012-06-30โ‚ฌ43.43 M42.8%
2011-06-30โ‚ฌ30.41 M2.56%
2010-06-30โ‚ฌ29.65 M29.41%
2009-06-30โ‚ฌ22.91 M-51.02%
2008-06-30โ‚ฌ46.78 M78.76%
2007-06-30โ‚ฌ26.17 M24.73%
2006-06-30โ‚ฌ20.98 M8.95%
2005-06-30โ‚ฌ19.25 M55.6%
2004-06-30โ‚ฌ12.37 M-26.79%
2003-06-30โ‚ฌ16.9 M-41.18%
2002-06-30โ‚ฌ28.74 M-25.05%
2001-06-30โ‚ฌ38.34 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ2.98 B 804.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.39 B 926.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.92 M-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.37 B 317.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ32.93 B 9,861.69%๐Ÿ‡บ๐Ÿ‡ธ USA